ADVERSE-EFFECTS FROM METOPROLOL ARE NOT GENERALLY ASSOCIATED WITH OXIDATION STATUS

被引：27

作者：

CLARK, DWJ ^{[1
]}

MORGAN, AKW ^{[1
]}

WAALMANNING, H ^{[1
]}

机构：

[1] UNIV OTAGO,SCH MED,WELLCOME MED RES INST,DEPT MED,DUNEDIN,NEW ZEALAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 18卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02573.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：965 / 967

页数：3

相关论文

共 7 条

[1] ANTIPYRINE METABOLISM IN RELATION TO POLYMORPHIC OXIDATIONS OF SPARTEINE AND DEBRISOQUINE
EICHELBAUM, M
BERTILSSON, L
SAWE, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) : 317 - 321
[2] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[3] IDLE JR, 1983, LANCET, V1, P1388
[4] LENNARD MS, 1983, NEW ENGL J MED, V308, P965
[5] DEFECTIVE METABOLISM OF METOPROLOL IN POOR HYDROXYLATORS OF DEBRISOQUINE
LENNARD, MS
SILAS, JH
FREESTONE, S
TREVETHICK, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) : 301 - 303
[6] OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE
LENNARD, MS
SILAS, JH
FREESTONE, S
RAMSAY, LE
TUCKER, GT
WOODS, HF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) : 1558 - 1560
[7] IMPAIRED OXIDATION OF DEBRISOQUINE IN PATIENTS WITH PERHEXILINE NEUROPATHY
SHAH, RR
OATES, NS
IDLE, JR
SMITH, RL
LOCKHART, JDF
[J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6312) : 295 - 299